N@N

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $415 on, Jan 9th, 2024

Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $415 on, Jan 9th, 2024.

Olivia has made no other calls on VRTX in the last 4 months.

There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 3 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $379 on, Thursday, December 14th, 2023
• Paul Matteis of "Stifel" Reiterated at Hold and Held Target at $373 on, Wednesday, November 22nd, 2023
• Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023

These are the ratings of the 5 analyists that currently disagree with Olivia

---

• Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $397 on, Monday, December 11th, 2023
• Gena Wang of "Barclays" Maintained at Buy with Increased Target to $415 on, Monday, December 11th, 2023
• Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023
• Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
• Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023

Contributing Sources

---